We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.08%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$42.8B
AUM Growth
+$3.35B
(+8.5%)
Cap. Flow
+$1.35B
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
14.82%
Holding
2,894
New
39
Increased
2,631
Reduced
168
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$21.8M |
| 2 |
Chevron
CVX
|
+$20.5M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$19.7M |
| 4 |
Incyte
INCY
|
+$17.8M |
| 5 |
ExxonMobil
XOM
|
+$16.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SE
Spectra Energy Corp Wi
SE
|
+$49.6M |
| 2 |
STJ
St Jude Medical
STJ
|
+$41.1M |
| 3 |
LLTC
Linear Technology Corp
LLTC
|
+$30.3M |
| 4 |
HAR
Harman International Industries
HAR
|
+$13.8M |
| 5 |
ENH
Endurance Specialty Holdings Ltd
ENH
|
+$10.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Technology | 15.06% |
| 3 | Healthcare | 13.05% |
| 4 | Industrials | 10.88% |
| 5 | Consumer Discretionary | 9.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MFA
1226
MFA Financial
MFA
$926M
| $3.51M | 0.01% |
108,639
+2,528
| +2% | +$80.6K |
|
|
JCP
1227
DELISTED
J.C. Penney Company, Inc.
JCP
| $3.51M | 0.01% |
569,469
+31,526
| +6% | +$208K |
|
|
RDC
1228
DELISTED
Rowan Companies Plc
RDC
| $3.51M | 0.01% |
225,119
+92
| +0% | +$1.62K |
|
|
DOC
1229
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $3.5M | 0.01% |
176,165
+14,044
| +9% | +$268K |
|
|
NP
1230
DELISTED
Neenah, Inc. Common Stock
NP
| $3.49M | 0.01% |
46,762
+10,478
| +29% | +$828K |
|
1231
EXL Service
EXLS
$5.14B
| $3.48M | 0.01% |
367,790
+94,580
| +35% | +$887K |
|
1232
Banner Corp
BANR
$2.39B
| $3.48M | 0.01% |
62,602
+15,011
| +32% | +$857K |
|
|
QCP
1233
DELISTED
Quality Care Properties, Inc.
QCP
| $3.48M | 0.01% |
184,480
+12,337
| +7% | +$219K |
|
1234
LPL Financial
LPLA
$28.3B
| $3.46M | 0.01% |
86,744
+7,936
| +10% | +$312K |
|
1235
MasTec
MTZ
$20.8B
| $3.45M | 0.01% |
86,169
+3,330
| +4% | +$127K |
|
1236
Insulet
PODD
$11.5B
| $3.45M | 0.01% |
80,065
+2,092
| +3% | +$89.7K |
|
|
TWO
1237
Two Harbors Investment
TWO
$1.27B
| $3.45M | 0.01% |
44,946
+5,137
| +13% | +$375K |
|
1238
Apogee Enterprises
APOG
$826M
| $3.44M | 0.01% |
57,766
+16,229
| +39% | +$930K |
|
1239
KB Home
KBH
$3.37B
| $3.44M | 0.01% |
173,123
+5,189
| +3% | +$90.8K |
|
1240
Northwest Bancshares
NWBI
$2.3B
| $3.43M | 0.01% |
203,540
+53,355
| +36% | +$935K |
|
1241
Simmons First National
SFNC
$3.41B
| $3.42M | 0.01% |
124,008
+33,864
| +38% | +$996K |
|
1242
Cooper-Standard Automotive
CPS
$523M
| $3.42M | 0.01% |
30,795
+9,583
| +45% | +$1.04M |
|
1243
Enerpac Tool Group
EPAC
$1.83B
| $3.41M | 0.01% |
129,421
+35,016
| +37% | +$941K |
|
1244
Sinclair Inc
SBGI
$992M
| $3.4M | 0.01% |
84,049
+3,467
| +4% | +$128K |
|
|
HW
1245
DELISTED
Headwaters Inc
HW
| $3.4M | 0.01% |
144,971
+41,818
| +41% | +$974K |
|
|
WDR
1246
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $3.39M | 0.01% |
199,402
+2,441
| +1% | +$44.7K |
|
|
CXP
1247
DELISTED
COLUMBIA PROPERTY TRUST, INC.
CXP
| $3.39M | 0.01% |
152,189
+16,629
| +12% | +$371K |
|
1248
AZZ Inc
AZZ
$4.35B
| $3.38M | 0.01% |
56,877
+14,527
| +34% | +$858K |
|
|
PGRE
1249
DELISTED
Paramount Group
PGRE
| $3.38M | 0.01% |
208,353
+20,086
| +11% | +$334K |
|
|
VRNT
1250
DELISTED
Verint Systems
VRNT
| $3.38M | 0.01% |
152,849
+3,047
| +2% | +$59.4K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2017 Portfolio in Review
As of Q1 2017, RhumbLine Advisers held 2,894 positions worth $42.8B, up 8.5% from $39.5B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
RhumbLine Advisers deployed $1.35B of net new capital in Q1 2017, opening 39 new positions and adding to 2,631 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Biogen, an estimated $8.21M trimmed.
- RhumbLine Advisers's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 197,812 shares worth $10.8M.
- RhumbLine Advisers added most to Abbott in Q1 2017, an estimated $21.8M increase.
- RhumbLine Advisers's biggest Q1 2017 reduction was Biogen, cutting an estimated $8.21M.
- RhumbLine Advisers fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $49.6M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $42.8B portfolio in Q1 2017.
- RhumbLine Advisers opened 39 new positions and closed 44 in Q1 2017.
- RhumbLine Advisers's portfolio value rose 8.5% quarter-over-quarter to $42.8B.
Based on RhumbLine Advisers's 13F filing for Q1 2017, filed 2 May 2017.